Performant/$PHLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Performant
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
Ticker
$PHLT
Sector
Primary listing
Employees
964
Headquarters
Website
Performant Metrics
BasicAdvanced
$622M
-
-$0.01
0.41
-
Price and volume
Market cap
$622M
Beta
0.41
52-week high
$7.75
52-week low
$2.17
Average daily volume
836K
Financial strength
Current ratio
2.641
Quick ratio
2.443
Long term debt to equity
10.392
Total debt to equity
11.044
Interest coverage (TTM)
-0.04%
Profitability
EBITDA (TTM)
1.852
Gross margin (TTM)
23.66%
Net profit margin (TTM)
-0.64%
Operating margin (TTM)
-0.03%
Effective tax rate (TTM)
-1.96%
Revenue per employee (TTM)
$140,000
Management effectiveness
Return on assets (TTM)
-0.03%
Return on equity (TTM)
-1.12%
Valuation
Price to revenue (TTM)
4.404
Price to book
7.43
Price to tangible book (TTM)
17.51
Price to free cash flow (TTM)
-1,372.027
Free cash flow yield (TTM)
-0.07%
Free cash flow per share (TTM)
-0.006
Growth
Revenue change (TTM)
15.21%
Earnings per share change (TTM)
-86.30%
3-year revenue growth (CAGR)
6.75%
10-year revenue growth (CAGR)
-1.46%
3-year earnings per share growth (CAGR)
-56.17%
10-year earnings per share growth (CAGR)
-21.82%
What the Analysts think about Performant
Analyst ratings (Buy, Hold, Sell) for Performant stock.
Bulls say / Bears say
Performant agreed to be acquired by Machinify at $7.75 per share, representing a 139% premium to the 90-day VWAP and valuing the company at approximately $670 million, demonstrating strong M&A interest and significant shareholder value creation. (Nasdaq)
The company secured the New York State Medicaid Recovery Audit Contractor contract, expected to generate double-digit millions in annual revenue at steady-state, thereby significantly enhancing its government segment and revenue visibility. (Nasdaq)
Preliminary Q2 2025 results forecast revenues of $37.8 million, net income of $2.1 million, and adjusted EBITDA of $6.2 million, indicating sequential growth and improved profitability. (Nasdaq)
The $670 million acquisition by Machinify is contingent on stockholder and regulatory approvals and customary closing conditions, posing execution risk until closing, expected by end-2025. (Nasdaq)
In Q4 2024, Performant reported a net loss of $0.5 million and a full-year adjusted net loss of $4.5 million, highlighting ongoing profitability challenges prior to expected synergies from the Machinify merger. (BusinessWire)
The company withdrew its 2025 full-year guidance and cancelled its Q2 earnings call in light of the acquisition, reducing investor visibility into near-term financial performance. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Performant Financial Performance
Revenues and expenses
Performant Earnings Performance
Company profitability
Performant News
AllArticlesVideos
PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc. - PHLT
Business Wire4 weeks ago
Shareholder Alert: The Ademi Firm Continues to Investigate Whether Performant Healthcare Inc. is Obtaining a Fair Price for its Public Shareholders
Business Wire1 month ago
Shareholder Alert: The Ademi Firm Investigates Whether Performant Healthcare Inc. Is Obtaining a Fair Price for Its Public Shareholders
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Performant stock?
Performant (PHLT) has a market cap of $622M as of October 19, 2025.
What is the P/E ratio for Performant stock?
The price to earnings (P/E) ratio for Performant (PHLT) stock is 0 as of October 19, 2025.
Does Performant stock pay dividends?
No, Performant (PHLT) stock does not pay dividends to its shareholders as of October 19, 2025.
When is the next Performant dividend payment date?
Performant (PHLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Performant?
Performant (PHLT) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.